Cobalt XT  ICDs and CRT-Ds

Cobalt™ XT ICDs and CRT-Ds with BlueSync™ technology enable tablet-based programming and app-based remote monitoring. These devices include an automated antitachycardia pacing (ATP) algorithm and are compatible with a simplified heart failure risk stratification tool. 

Download Brochure

Overview

The Future Is Here

Meet Cobalt XT ICDs and CRT-Ds

Exclusive ATP algorithm, heart failure risk stratification, tablet-based programming and app-based remote monitoring, extended longevity, and 40 J on all shocks.

Unmatched Feature Suite

Extended Longevity

Mean longevity projections based on CareLink™ patient data*

Graph depicting Cobalt XT's longevity projections against Claria and Amplia MRI devices
Graph depicting Cobalt XT dual chamber's longevity projections against Evera MRI XT and Evera MRI S dual chamber ICDs
Graph depicting Cobalt XT single chamber's longevity projections against Visia AF MRI single chamber device

Increased Energy Delivery

Option for 40 J energy delivery on all shocks, including the first

Maximum Programmed Energy 40 J

Maximum

 

Delivered

Energy<sup>‡</sup>

40 J

Maximum

 

Stored

Energy<sup>§</sup>

47 J

Intrinsic ATP Algorithm

Intrinsic ATP™ is the only automated and smart ventricular antitachycardia pacing (ATP) algorithm that provides individualized therapy in real time.

In a virtual modeling study, Intrinsic ATP’s termination rate was 17 percentage points higher than traditional ATP (burst) with no difference in acceleration rate.7

% of termination 
Graph depicting iATP's 17% increase in termination rate compared to traditional ATPs
White gear icon

Simplified 

Programming 

On/Off

White heart icon

Individualized

Therapy 

ATP designed for each VT

White clock icon

Real-time

Response 

If VT is redetected, iATP automatically adjusts the next ATP sequence.

Exclusive Algorithms to Manage AF

Discover Cobalt XT's full suite of algorithms to help detect, reduce, and respond to atrial fibrillation (AF).

Reimagined Connectivity

BlueSync Technology

Cobalt XT ICDs and CRT-Ds with BlueSync technology enable secure, wireless communication.

CareLink SmartSync interface shown on tablet

Tablet-based CareLink SmartSync™ device manager

Cobalt XT ICDs and CRT-Ds with Bluetooth icon on white background

Cobalt XT ICDs and CRT-Ds

MyCareLink Heart app and MyCareLink Relay home communicator on white background

MyCareLink Heart™ mobile app or MyCareLink Relay™ Home Communicator

Get Connected service shown on desktop monitor

CareLink network and the
Get Connected service

Streamlined Workflows & Heart Failure Management 

TriageHF Technology

TriageHF™¶ is a simplified, integrated heart failure risk assessment tool that alerts clinicians to clinically relevant changes in a patient’s status that may lead to a heart failure decompensation.

While bullseye icon

Simple Risk Stratification

HIGH
MEDIUM
LOW

White icon of a physician standing next to a sitting patient

Streamlined Clinic Management

TriageHF-enabled
clinics# can leverage
the technology for
all ICD & CRT
patients with
OptiVol™, with
backward
compatibility.

White icon of an arrow trending upward

Automated  Clinic Alerts

Automated
notifications
to enable
clinical action

System Features & Exclusive Algorithms

Discover exclusive features and algorithms available in Cobalt XT ICDs and CRT-Ds.

Model Specifications

Additional Resources 

Medtronic 24-hour Support

1-800-505-4636

Medtronic Academy

Find additional feature information along with a variety of educational resources and tools.

Visit Medtronic Academy
*

These values should not be interpreted as precise numbers. Individual patient results may vary based on their specific programming and experience.

With AdaptivCRT™ programmed to BiV and LV.

Energy delivered at connector block into a 50 Ω ± 1% load.

§

Energy stored at charge end on capacitor.

||

From ADVANCE III, using ATP during charging along with NID = 30/40 programming, ATP reduced shocked episodes by 52%.8

TriageHF is not an alarm. The TriageHF assessment does not replace heart failure assessments in standard clinical practice. Medical treatment should not be modified remotely based solely on the TriageHF assessment. Interpretation of the TriageHF assessment requires clinical judgement by a medical professional. The TriageHF assessment should be used in conjunction with professional guidelines for patient management decisions.

#

TriageHF requires clinic activation. Contact your local Medtronic sales representative for activation requirements

References

1

Medtronic Claria MRI™ Quad CRT-D SureScan™ & Amplia MRI™ Quad CRT-D SureScan™ Mean Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201802366 EN.

2

Medtronic Cobalt™ XT HF Quad MRI SureScan™ Model DTPA2QQ device manual.

3

Medtronic Evera MRI™ XT DR SureScan™ and Evera MRI™ S DR SureScan™ Mean Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201802366 EN.

4

Medtronic Cobalt™ XT DR ICD MRI SureScan™ Model DDPA2D4 device manual.

5

Medtronic Visia AF™ VR SureScan™ Mean Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201802366 EN.

6

Medtronic Cobalt™ XT VR ICD MRI SureScan™ Model DVPA2D4 device manual.

7

Swenson DJ, Taepke RT, Blauer JJE, et al. Direct comparison of a novel antitachycardia pacing algorithm against present methods using virtual patient modeling. Heart Rhythm. September 2020;17(9):1602-1608.

8

Arenal A, Proclemer A, Kloppe A, et al. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace. November 2016;18(11):1719-1725.

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.